Maresin1 regulates neutrophil recruitment and IL-10 expression in Aspergillus fumigatus keratitis.


Journal

International immunopharmacology
ISSN: 1878-1705
Titre abrégé: Int Immunopharmacol
Pays: Netherlands
ID NLM: 100965259

Informations de publication

Date de publication:
Apr 2019
Historique:
received: 08 10 2018
revised: 19 12 2018
accepted: 22 01 2019
pubmed: 29 1 2019
medline: 19 7 2019
entrez: 29 1 2019
Statut: ppublish

Résumé

Maresin1, a lipid mediator derived from polyunsaturated fatty acids, has been shown to suppress the inflammatory response in various inflammatory diseases. However, its effects in fungal keratitis are still uncertain. In this study, we investigated the role of maresin1 (MaR1) in Aspergillus fumigatus keratitis of the eye in a mouse model. Mouse corneas were infected with A. fumigatus by corneal intrastromal injection. Two hours after infection, maresin1 (5 ng/5 μl) was delivered by subconjunctival injection. Then, topical administration of maresin1 (5 ng/3 μl) was applied to mouse corneas twice a day from day 1 to day 5. The development of FK lesions, the production of chemokines, the production of inflammation cytokines and the levels of p-GSK3β were measured via slit-lamp biomicroscope, quantitative polymerase chain reaction (qRT-PCR) and western blot. The presence of neutrophils in the cornea was detected by immunofluorescence staining and myeloperoxidase. The effect of maresin1 on A. fumigatus stimulated mouse macrophage RAW264.7 cells was assessed via PCR and Western blot. In our study, administration of maresin1 reduced the severity of fungal keratitis with infiltration of fewer neutrophils and reduced levels of the chemokine CXCL1, while the anti-inflammatory cytokines such as IL-10 were enhanced compared with the PBS group. Additionally, in vitro studies showed that treatment with maresin1 inhibited the production of the chemokine CXCL1 and enhanced IL-10 levels in A. fumigatus stimulated RAW264.7 mouse macrophages. Moreover, levels of p-GSK3β increased after maresin1 treatment in A. fumigatus stimulated RAW264.7 cells. Taken together, these findings demonstrate that treatment with maresin1 moderates corneal inflammation through reducing neutrophil recruitment and levels of the chemokine CXCL1 and enhancing the anti-inflammatory cytokine IL-10 in A. fumigatus keratitis. Additionally, maresin1 alters levels of GSK3β phosphorylation to regulate CXCL1 and IL-10 expression in response to A. fumigatus infection. Topical administration of maresin1 may emerge as a novel anti-inflammatory molecule and has a protective role in A. fumigatus keratitis.

Identifiants

pubmed: 30690344
pii: S1567-5769(18)30838-5
doi: 10.1016/j.intimp.2019.01.032
pii:
doi:

Substances chimiques

7,14-dihydroxydocosa-4,8,10,12,16,19-hexaenoic acid 0
Anti-Inflammatory Agents 0
Chemokine CXCL1 0
Interleukin-10 130068-27-8
Docosahexaenoic Acids 25167-62-8

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

103-108

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Qing Tang (Q)

Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China.

Chengye Che (C)

Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China.

Jing Lin (J)

Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China.

Hong He (H)

Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China.

Wenyi Zhao (W)

Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China.

Leyu Lv (L)

Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China.

Guiqiu Zhao (G)

Department of Ophthalmology, The Affiliated Hospital of Qingdao University, Qingdao, Shandong Province, China. Electronic address: zhaoguiqiu_good@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH